BIIB
Biogen Inc.
222.90$
-0.3%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 26.1% | 25.9% | 21.7% | 38.8% | 25.9% | 23.8% | 23.8% | 35.8% | 35.7% | 21.8% | 26.7% | 43.1% | 32.3% | |
| 73.9% | 74.1% | 78.3% | 61.2% | 74.1% | 76.2% | 76.2% | 64.2% | 64.3% | 78.2% | 73.3% | 56.9% | 67.7% | |
| 31.5% | 27.1% | 22.9% | 24.0% | 27.3% | 27.8% | 22.5% | 20.0% | 15.1% | 22.3% | 23.1% | 18.1% | 19.6% | |
| 31.2% | 22.5% | 25.4% | 22.5% | 23.9% | 24.9% | 23.5% | 22.1% | 24.2% | 30.0% | 24.5% | 25.9% | 26.1% | |
| 61.3% | 52.6% | 48.1% | 46.4% | 50.7% | 55.5% | 46.1% | 42.0% | 39.3% | 80.7% | 57.3% | 45.3% | 54.9% | |
| 12.7% | 21.5% | 30.1% | 14.9% | 23.4% | 20.7% | 30.1% | 22.2% | 25.0% | -2.5% | 16.0% | 11.6% | 12.8% | |
| 2.5% | 3.0% | 3.0% | 2.5% | 2.4% | 2.4% | 2.5% | 2.7% | 2.7% | 3.0% | 2.7% | 3.0% | 2.9% | |
| -5.6% | 12.2% | 20.3% | 28.3% | 18.3% | 11.9% | 12.8% | 28.1% | 22.7% | -9.3% | 15.2% | 4.8% | 8.6% | |
| -2.9% | 1.8% | 3.1% | 4.7% | 2.5% | 1.0% | 2.9% | 4.1% | 3.7% | -7.1% | 2.3% | 1.3% | 0.2% | |
| -2.7% | 10.5% | 17.2% | 23.7% | 15.8% | 10.9% | 9.9% | 24.0% | 19.0% | -2.1% | 12.9% | 3.6% | 8.4% | |
| 15.6% | 25.2% | 34.0% | 39.3% | 29.0% | 28.2% | 35.6% | 42.0% | 33.7% | 9.3% | 22.3% | 2.9% | 16.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.